Weight loss injections are generally appropriate if: Your BMI is between 27-35 with obesity-related health conditions (or 30+ without) Youre committed to physician supervision and regular follow-ups You want to try a non-surgical option first You understand the medication is a long-term commitment, not a short course They may NOT be the right long-term fit if your BMI is over 35 with significant comorbidities, if youve already tried medications without reaching your target weight loss, experienced intolerable side effects, or find the ongoing cost unsustainable
At the same time, Ozempic has emerged
[1] [2] Symptoms that have been described include: Injection site reactions : redness, swelling, itching, or mild bruising at the site of subcutaneous administration consistent with class effects seen with semaglutide and tirzepatide (see eMC SmPCs for Wegovy, Ozempic, and Mounjaro for comparator data) Pruritus or urticaria : patchy or widespread skin itching or redness, which may reflect a hypersensitivity response again consistent with known class effects of GLP-1-based therapies [17] Generalised skin sensitivity : heightened sensitivity to touch, temperature, or pressure beyond the injection site
Expert testimony preparations
These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 277 million patient records from 1,500 hospitals and more than 36,000 clinics from all 50 states, Lebanon, and Saudi Arabia
Semaglutides role in promoting a balanced blood sugar level can further enhance mental function and prevent the common mid-afternoon energy slumps associated with high carb diets